Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver

Drug Metabolism and Disposition

Volumn 26, Issue 5, 1998, Pages 483-489

  Amato, Giada ^b   Longo, Vincenzo ^b   Mazzaccaro, Arturo ^b   Gervasi, Pier Giovanni ^a  

^a CNR   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL; ANILINE; CHLORZOXAZONE; DIMETHYLNITROSAMINE DEMETHYLASE; OXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; DRUG HYDROXYLATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; FEMALE; LIVER MICROSOME METABOLISM; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CHLORZOXAZONE; CYTOCHROME P-450 CYP2E1; FEMALE; HYDROXYLATION; MACACA FASCICULARIS; MALE; MICROSOMES, LIVER; MUSCLE RELAXANTS, CENTRAL; NITROPHENOLS;

ANIMALIA; MACACA FASCICULARIS;

EID: 0031950111     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Bullock P, Pearce R, Draper A, Podval J, Bracken W, Veltman J, Thomas P and Parkinson A (1995) Induction of liver microsomal cytochrome P450 in cynomolgus monkeys. Drug Metab Dispos 23:736-748.
2. Camus A-M, Geneste O, Honkakoski P, Béréziat J-C, Henderson CJ, Wolf CR, Bartsch H and Lang MA (1993) High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol Carcinog 7:268-275.
3. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier J-C, Guillouzo A, Beaune P and Berthou F (1993) Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6:852-857.
4. Dalet-Beluche C, Boulenc X, Fabre G, Maurel P and Bonfils C (1992) Purification of two cytochrome P450 isozymes related to CYP2A and CYP3A gene families from monkey (baboon, Papio papio) liver microsomes. J Biochem (Tokyo) 204:641-648.
5. Feierman DE and Cederbaum AI (1987) Increased sensitivity of the microsomal oxidation of ethanol to inhibition by pyrazole and 4-methylpyrazole after chronic ethanol treatment Biochem Pharmacol 36:3277-3283.
6. Funae Y and Imaoka S (1993) Cytochrome P450 in rodents, in Cytochrome P450 (Schenkman JB and Helmut G eds) vol 105, pp 221-238, Springer-Verlag, New York.
7. Girre C, Lucas D, Hispard E, Menez C, Dally S and Menez JF (1994) Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 47:1503-1508.
8. Guengerich FP, Kim DH and Iwasaki M (1991) Role of human cytochrome P4502E1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179.
9. Halpert JR, Guengerich FP, Bend JR and Correia MA (1994) Contemporary issue in toxicology: selective inhibitors of cytochrome P450. Toxicol Appl Pharmacol 125:163-175.
10. Jayyosi Z, Knoble D, Mue M, Erick J, Thomas PE and Kelley M (1995) Cytochrome P450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. J Pharmacol Exp Ther 273:1156-1161.
11. Kaminsky LS, Fasco MJ and Guengerich FP (1981) Production and application of antibodies to rat liver cytochrome P450. Methods Enzymol 74:262-272.
12. Klotz AV, Stegeman JJ and Walsh C (1984) An alternative 7-ethoxyresorufin assay: a continuous visible spectrophotometric method for measurement of cytochrome P450 monooxygenase activity. Anal Biochem 140:138-145.
13. Ko IY, Park SS, Song BJ, Patten C, Tan Y, Han YC, Yang CS and Gelboin HV (1987) Monoclonal antibodies to ethanol-induced rat liver cytochrome P450 that metabolizes aniline and nitrosamines. Cancer Res 47:3101-3109.
14. Komori M, Kikuchi O, Kitada M and Kamataki T (1992a) Molecular cloning of monkey P450 1A1 cDNA and expression in yeast. Biochim Biophys Acta 1131:23-29.
15. Komori M, Kikuchi O, Sakuma T, Funaki J, Kitada M and Kamataki T (1992b) Molecular cloning of monkey liver cytochrome P450 cDNAs: similarity of the primary sequences to human cytochromes P450. Biochim Biophys Acta 1171:141-146.
16. Koop DR, Laetherm CL and Tierney DJ (1989) The utility of p-nitrophenol hydroxylation in P450 2E1 analysis. Drug Metab Rev 20:541-551.
17. Krijgsheld KR and Gram TE (1984) Selective induction of renal microsomal cytochrome P450-linked monooxygenases by 1,1-dichloroethylene in mice. Biochem Pharmacol 33:1951-1956.
18. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685.
19. coh substrate specificity by mutation of a single amino-acid residue. Nature (Lond) 339:632-634.
20. Longo V, Citti L and Gervasi PG (1986) Metabolism of diethylnitrosamine by nasal mucosa and hepatic microsomes from hamster and rat: species specificity of nasal mucosa. Carcinogenesis (Lond) 7:1323-1328.
21. Longo V, Mazzaccaro A, Naldi F and Gervasi PG (1991) Drug metabolizing enzymes in liver olfactory and respiratory epithelium of cattle. J Biochem Toxicol 6:123-128.
22. Longo V, Mazzaccaro A, Ventura P and Gervasi PG (1992) Drug-metabolizing enzymes in respiratory nasal mucosa and liver of cynomolgus monkey. Xenobiotica 22:427-431.
23. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
24. Lucas D, Berthou F, Dreano Y, Floch HH and Menez JF (1990) Ethanol-inducible cytochrome P450: assessment of substrate-specific chemical probes in rat liver microsomes. Alcohol Clin Exp Res 14:590-594.
25. Mäenpää J, Sigusch H, Raunio H, Syngelmä T, Vuorela P, Vuorela H and Pelkonen O (1993) Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem Pharmacol 45:1035-1042.
26. McKinney MM and Parkinson A (1987) A simple, non-chromatographic procedure to purify immunoglobins from serum and ascites fluid. J Immunol Methods 96:271-278.
27. Menicagli S, Longo V, Mazzaccaro A and Gervasi PG (1994) Microsomal metabolism of N,N-diethylacetamide and N,N-dimethylacetamide and their effects on drug-metabolizing enzymes of rat liver. Biochem Pharmacol 48:717-726.
28. Mikalsen A, Alexander J, Wallen H, Ingelman-Sundberg M and Andersen RA (1991) Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes. Carcinogenesis (Lond) 12:825-831.
29. Murray M and Reidy GF (1990) Selectivity in the inhibition of mammalian cytochromes P450 by chemical agents. Pharmacol Rev 42:85-101.
30. Namkung MJ, Yang HL, Hulla JE and Juchau MR (1988) On the substrate specificity of cytochrome P4503A1. Mol Pharmacol 34:628-637.
31. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC and Neben DW (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
32. Ohi H, Toratani S, Komori M, Miura T, Kitada M and Kamataki T (1989) Comparative study of cytochrome P450 in liver microsomes. Biochem Pharmacol 38:361-365.
33. Ohmori S, Chiba K, Nakasa H, Horie T and Kitada M (1994) Characterization of monkey cytochrome P450, P450 CMLd, responsible for S-mephenytoin 4′-hydroxylation in hepatic microsomes of cynomolgus monkeys. Arch Biochem Biophys 311:395-401.
34. Ohmori S, Horie T, Guengerich FP, Kiuchi M and Kitada M (1993a) Purification and characterization of two forms of hepatic microsomal cytochrome P450 from untreated cynomolgus monkeys. Arch Biochem Biophys 305:405-413.
35. Ohmori S, Shirakawa C, Motohashi K, Yoshida H, Abe H, Nakamura T, Horie T, Kitagawa H, Asaoka K, Rikihisa T, Kanakubo Y and Kitada M (1993b) Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6. Mol Pharmacol 43:183-190.
36. Omura T and Sato R (1964) The carbon monoxide-binding protein of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 293:2370-2378.
37. Parkinson A (1996) Biotransformation of xenobiotics, in Casarett & Doull's Toxicology, the Basic Science of Poisons (Klaassen CD, Amdur MO and Doull J eds) 5th ed, pp 113-186, McGraw-Hill, New York.
38. Peter R, Böcker R, Beaune PH, Iwasaki M, Guengerich FP and Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem Res Toxicol 3:566-573.
39. Platt KL, Molitor E, Dohemer J, Dogra S and Oesch F (1989) Genetically engineered V79 Chinese hamster cell expression of purified cytochrome P450IIB1 monooxygenase activity. J Biochem Toxicol 4:1-6.
40. Puccini P, Menicagli S, Longo V, Santucci A and Gervasi PG (1992) Purification and characterization of an acetone-inducible cytochrome P450 from hamster liver microsomes. Biochem J 287:863-870.
41. Raucy J, Fernandes P, Black M, Yang SL and Koop DR (1987) Identification of a human liver cytochrome P450 exhibiting catalytic and immunochemical similarities to cytochrome P450 3a of rabbit liver. Biochem Phamacol 36:2921-2926.
42. Reinke LA and Moyer MJ (1985) p-Nitrophenol hydroxylation: a microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 13:548-552.
43. Reinke LA, Sexter SH and Rikans LE (1985) Comparison of ethanol and imidazole pretreatments on hepatic monooxygenase activities in the rat. Res Commun Chem Pathol Pharmacol 47:97-106.
44. Roos PH, Golub-Ciosk B, Kallweit P, Kauczinski D and Hanstein WB (1993) Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes. Biochem Pharmacol 45:2239-2250.
45. Sharer JE, Shipley LA, Vandenbranden MR, Binkley SN and Wrighton SA (1995) Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metab Dispos 23:1231-1241.
46. Stevens JC, Shipley LA, Cashman JR, Vandenbranden M and Wrighton SA (1993) Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. Drug Metab Dispos 21:753-760.
47. Tassaneeyakul W, Veronese ME, Birken DJ, Gonzalez FJ and Miners JO (1993) Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem Pharmacol 46:1975-1981.
48. Thomas PE, Bandiera S, Maines SL, Ryan DE and Levin W (1987) Regulation of cytochrome P450j, a high-affinity N-nitrosodimethylamine demethylase, in rat hepatic microsomes. Biochemistry 26:2280-2289.
49. Towbin H, Staehelin T and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
50. Tu YY and Yang CS (1983) High-affinity nitrosamine dealkylase system in rat liver microsomes and its induction by fasting. Cancer Res 43:623-629.
51. Weaver RJ, Thompson S, Smith G, Dickins M, Elcombe CR, Mayer RT and Burke MD (1994) A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochem Pharmacol 47:763-773.
52. Wu D, Otton SV, Morrow P, Inaba T, Kalow W and Sellers EM (1993) Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitro. J Pharmacol Exp Ther 266:715-719.
53. Yang CS, Yoo J-SH, Ishizaki H and Hong J (1990) Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev 22:147-159.